UBS Group’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.3K Sell
18,508
-45,531
-71% -$27.8K ﹤0.01% 7474
2025
Q1
$48.3K Sell
64,039
-139,190
-68% -$105K ﹤0.01% 6336
2024
Q4
$196K Buy
203,229
+161,625
+388% +$155K ﹤0.01% 5265
2024
Q3
$59.9K Sell
41,604
-119,231
-74% -$172K ﹤0.01% 5499
2024
Q2
$195K Buy
160,835
+107,297
+200% +$130K ﹤0.01% 4556
2024
Q1
$126K Buy
53,538
+30,960
+137% +$72.8K ﹤0.01% 4966
2023
Q4
$42.7K Buy
22,578
+18,241
+421% +$34.5K ﹤0.01% 5433
2023
Q3
$5.94K Buy
4,337
+4,310
+15,963% +$5.91K ﹤0.01% 6191
2023
Q2
$66 Buy
+27
New +$66 ﹤0.01% 7482
2023
Q1
Sell
-117,589
Closed -$1.05M 8425
2022
Q4
$1.05M Buy
117,589
+100,320
+581% +$897K ﹤0.01% 3102
2022
Q3
$246K Buy
+17,269
New +$246K ﹤0.01% 3902
2022
Q2
Sell
-547
Closed -$11K 9188
2022
Q1
$11K Sell
547
-9,338
-94% -$188K ﹤0.01% 7227
2021
Q4
$173K Buy
9,885
+9,733
+6,403% +$170K ﹤0.01% 4773
2021
Q3
$1K Buy
+152
New +$1K ﹤0.01% 7970
2021
Q2
Sell
-1,693
Closed -$22K 8217
2021
Q1
$22K Buy
1,693
+1,119
+195% +$14.5K ﹤0.01% 6260
2020
Q4
$8K Sell
574
-826
-59% -$11.5K ﹤0.01% 6577
2020
Q3
$17K Buy
1,400
+63
+5% +$765 ﹤0.01% 5559
2020
Q2
$20K Buy
1,337
+753
+129% +$11.3K ﹤0.01% 5703
2020
Q1
$4K Sell
584
-87,411
-99% -$599K ﹤0.01% 6442
2019
Q4
$918K Buy
87,995
+86,923
+8,108% +$907K ﹤0.01% 3416
2019
Q3
$67K Buy
1,072
+1,001
+1,410% +$62.6K ﹤0.01% 5088
2019
Q2
$5K Sell
71
-186
-72% -$13.1K ﹤0.01% 6482
2019
Q1
$12K Sell
257
-121
-32% -$5.65K ﹤0.01% 5841
2018
Q4
$23K Buy
378
+47
+14% +$2.86K ﹤0.01% 5742
2018
Q3
$35K Buy
331
+111
+50% +$11.7K ﹤0.01% 5522
2018
Q2
$14K Buy
+220
New +$14K ﹤0.01% 6007